356 GENES FOUNDi
Show / hide columns Aggregate: Custom reports Download: XML | RDF | TSV | JSON | Custom TSV/JSON « prev | Page of 8 | next »
Genei Gene descriptioni x Evidencei x Tissuei Braini Single celli Subcelli Canceri Bloodi Cell linei Struct & Inti Prognostic p-valuei x
SH3GL2SH3 domain containing GRB2 like 2, endophilin A1
Kidney Renal Papillary Cell Carcinoma (TCGA): 5.05e-6
Glioblastoma Multiforme (validation): 5.52e-5
SH3RF3SH3 domain containing ring finger 3
Ovary Serous Cystadenocarcinoma (TCGA): 3.89e-4
Kidney Renal Clear Cell Carcinoma (TCGA): 4.65e-4
Ovary Serous Cystadenocarcinoma (validation): 9.44e-4
SLC25A42Solute carrier family 25 member 42
Kidney Renal Clear Cell Carcinoma (TCGA): 6.36e-8
Lung Adenocarcinoma (TCGA): 3.66e-4
Head and Neck Squamous Cell Carcinoma (TCGA): 7.68e-4
SLC27A3Solute carrier family 27 member 3
Pancreatic Adenocarcinoma (validation): 5.73e-5
Glioblastoma Multiforme (validation): 7.76e-5
Ovary Serous Cystadenocarcinoma (validation): 1.29e-4
Prostate Adenocarcinoma (TCGA): 1.38e-4
SLC29A4Solute carrier family 29 member 4
Glioblastoma Multiforme (TCGA): 6.53e-4
Stomach Adenocarcinoma (TCGA): 7.55e-4
SLFN13Schlafen family member 13
Kidney Renal Clear Cell Carcinoma (TCGA): 5.21e-5
Liver Hepatocellular Carcinoma (validation): 1.20e-4
Lung Squamous Cell Carcinoma (TCGA): 1.81e-4
SMC2Structural maintenance of chromosomes 2
Kidney Renal Clear Cell Carcinoma (TCGA): 1.50e-6
Lung Adenocarcinoma (TCGA): 3.84e-5
Liver Hepatocellular Carcinoma (validation): 2.97e-4
SNPHSyntaphilin
Kidney Renal Papillary Cell Carcinoma (TCGA): 1.00e-4
Pancreatic Adenocarcinoma (TCGA): 4.28e-4
SNRNP25Small nuclear ribonucleoprotein U11/U12 subunit 25
Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (TCGA): 3.00e-5
SP6Sp6 transcription factor
Lung Adenocarcinoma (TCGA): 8.76e-6
Stomach Adenocarcinoma (TCGA): 2.48e-4
SS18L2SS18 like 2
Liver Hepatocellular Carcinoma (validation): 2.71e-6
Kidney Chromophobe (TCGA): 1.12e-5
Liver Hepatocellular Carcinoma (TCGA): 8.23e-4
STK17ASerine/threonine kinase 17a
Lung Adenocarcinoma (validation): 8.69e-4
STK26Serine/threonine kinase 26
Kidney Renal Papillary Cell Carcinoma (TCGA): 2.53e-5
SUMF2Sulfatase modifying factor 2
Kidney Renal Clear Cell Carcinoma (TCGA): 1.97e-6
Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (TCGA): 4.54e-4
SURF6Surfeit 6
Breast Invasive Carcinoma (validation): 3.74e-5
Kidney Renal Clear Cell Carcinoma (TCGA): 1.09e-4
Uterine Corpus Endometrial Carcinoma (TCGA): 1.21e-4
Liver Hepatocellular Carcinoma (TCGA): 1.89e-4
SUZ12SUZ12 polycomb repressive complex 2 subunit
Kidney Renal Clear Cell Carcinoma (TCGA): 1.97e-5
Liver Hepatocellular Carcinoma (validation): 2.33e-5
Kidney Chromophobe (TCGA): 1.28e-4
SVBPSmall vasohibin binding protein
Liver Hepatocellular Carcinoma (TCGA): 1.66e-6
Kidney Renal Clear Cell Carcinoma (TCGA): 5.85e-4
Stomach Adenocarcinoma (TCGA): 9.56e-4
TAF1DTATA-box binding protein associated factor, RNA polymerase I subunit D
Pancreatic Adenocarcinoma (TCGA): 1.77e-4
Glioblastoma Multiforme (validation): 2.46e-4
Rectum Adenocarcinoma (TCGA): 8.80e-4
TBC1D14TBC1 domain family member 14
Kidney Renal Clear Cell Carcinoma (TCGA): 1.46e-6
Lung Adenocarcinoma (validation): 4.58e-4
Head and Neck Squamous Cell Carcinoma (TCGA): 4.74e-4
Breast Invasive Carcinoma (TCGA): 6.98e-4
Kidney Renal Papillary Cell Carcinoma (TCGA): 8.84e-4
TCF7L2Transcription factor 7 like 2
Kidney Renal Clear Cell Carcinoma (TCGA): 4.45e-8
Kidney Renal Clear Cell Carcinoma (validation): 5.87e-5
Bladder Urothelial Carcinoma (TCGA): 9.70e-4
TFDP2Transcription factor Dp-2
Liver Hepatocellular Carcinoma (TCGA): 2.56e-5
Rectum Adenocarcinoma (TCGA): 1.93e-4
Liver Hepatocellular Carcinoma (validation): 8.95e-4
Glioblastoma Multiforme (validation): 9.23e-4
TGM2Transglutaminase 2
Glioblastoma Multiforme (validation): 4.12e-6
Glioblastoma Multiforme (TCGA): 1.61e-4
Ovary Serous Cystadenocarcinoma (validation): 2.24e-4
Pancreatic Adenocarcinoma (validation): 8.51e-4
THUMPD2THUMP domain containing 2
TIGD1Tigger transposable element derived 1
Kidney Renal Clear Cell Carcinoma (TCGA): 2.84e-5
Colon Adenocarcinoma (TCGA): 4.88e-5
Lung Squamous Cell Carcinoma (validation): 5.63e-5
TM2D3TM2 domain containing 3
Breast Invasive Carcinoma (validation): 1.60e-4
TMA7Translation machinery associated 7 homolog
Lung Squamous Cell Carcinoma (TCGA): 2.02e-4
TMEM86BTransmembrane protein 86B
Pancreatic Adenocarcinoma (TCGA): 2.52e-4
TMPPETransmembrane protein with metallophosphoesterase domain
TNPO2Transportin 2
Kidney Renal Clear Cell Carcinoma (TCGA): 4.31e-5
Kidney Renal Papillary Cell Carcinoma (TCGA): 6.02e-4
TP53Tumor protein p53
Breast Invasive Carcinoma (validation): 5.06e-4
Prostate Adenocarcinoma (TCGA): 9.03e-4
TRIM45Tripartite motif containing 45
Thyroid Carcinoma (TCGA): 6.30e-5
Kidney Renal Papillary Cell Carcinoma (TCGA): 2.18e-4
TRMT11TRNA methyltransferase 11 homolog
TRNT1TRNA nucleotidyl transferase 1
Kidney Renal Clear Cell Carcinoma (TCGA): 1.26e-5
Rectum Adenocarcinoma (validation): 3.96e-4
Pancreatic Adenocarcinoma (TCGA): 5.36e-4
TSPAN31Tetraspanin 31
Kidney Renal Clear Cell Carcinoma (TCGA): 2.14e-7
Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (TCGA): 8.06e-5
Head and Neck Squamous Cell Carcinoma (TCGA): 5.02e-4
Breast Invasive Carcinoma (TCGA): 7.63e-4
UBE2MUbiquitin conjugating enzyme E2 M
Liver Hepatocellular Carcinoma (validation): 5.26e-7
Liver Hepatocellular Carcinoma (TCGA): 2.93e-5
Kidney Renal Clear Cell Carcinoma (TCGA): 5.69e-4
UGDHUDP-glucose 6-dehydrogenase
Kidney Renal Papillary Cell Carcinoma (TCGA): 1.17e-6
UNC119BUnc-119 lipid binding chaperone B
Kidney Renal Clear Cell Carcinoma (TCGA): 3.74e-9
Kidney Renal Clear Cell Carcinoma (validation): 1.86e-4
Rectum Adenocarcinoma (validation): 2.12e-4
Pancreatic Adenocarcinoma (validation): 8.21e-4
UNC13BUnc-13 homolog B
Kidney Renal Clear Cell Carcinoma (TCGA): 5.49e-8
Kidney Renal Papillary Cell Carcinoma (TCGA): 2.12e-4
Head and Neck Squamous Cell Carcinoma (TCGA): 2.39e-4
Lung Adenocarcinoma (TCGA): 3.07e-4
URI1URI1 prefoldin like chaperone
Rectum Adenocarcinoma (TCGA): 1.53e-5
Liver Hepatocellular Carcinoma (TCGA): 9.13e-5
Kidney Renal Clear Cell Carcinoma (TCGA): 1.62e-4
Ovary Serous Cystadenocarcinoma (TCGA): 2.45e-4
USP3Ubiquitin specific peptidase 3
Glioblastoma Multiforme (validation): 2.65e-4
UTP6UTP6 small subunit processome component
Kidney Renal Clear Cell Carcinoma (TCGA): 7.65e-8
Liver Hepatocellular Carcinoma (validation): 2.09e-5
Liver Hepatocellular Carcinoma (TCGA): 6.39e-5
Lung Adenocarcinoma (validation): 2.91e-4
VRK1VRK serine/threonine kinase 1
Kidney Renal Clear Cell Carcinoma (TCGA): 1.49e-7
Liver Hepatocellular Carcinoma (TCGA): 6.84e-6
Liver Hepatocellular Carcinoma (validation): 3.09e-5
Lung Squamous Cell Carcinoma (TCGA): 6.97e-5
Bladder Urothelial Carcinoma (TCGA): 8.41e-4
ZBTB24Zinc finger and BTB domain containing 24
Liver Hepatocellular Carcinoma (TCGA): 4.86e-4
Kidney Renal Papillary Cell Carcinoma (TCGA): 9.67e-4
ZFHX2Zinc finger homeobox 2
ZFP37ZFP37 zinc finger protein
Kidney Renal Clear Cell Carcinoma (TCGA): 2.15e-5
Kidney Renal Clear Cell Carcinoma (validation): 1.87e-4
ZKSCAN1Zinc finger with KRAB and SCAN domains 1
Kidney Renal Clear Cell Carcinoma (TCGA): 2.82e-4
Pancreatic Adenocarcinoma (validation): 7.45e-4
Ovary Serous Cystadenocarcinoma (TCGA): 8.27e-4
ZNF202Zinc finger protein 202
Liver Hepatocellular Carcinoma (TCGA): 3.04e-6
Glioblastoma Multiforme (validation): 4.47e-4
Rectum Adenocarcinoma (TCGA): 6.64e-4
Skin Cuteneous Melanoma (TCGA): 9.32e-4
Breast Invasive Carcinoma (validation): 9.78e-4
ZNF263Zinc finger protein 263
Kidney Renal Clear Cell Carcinoma (TCGA): 1.39e-5
ZNF32Zinc finger protein 32
Breast Invasive Carcinoma (TCGA): 3.86e-4
Pancreatic Adenocarcinoma (TCGA): 5.82e-4
Glioblastoma Multiforme (validation): 7.79e-4
ZNF341Zinc finger protein 341
Liver Hepatocellular Carcinoma (TCGA): 5.37e-5
« prev | Page of 8 | next »